AIDS, HIV & STDs Research Reports
AIDS Associated Dementia - Pipeline Review, H1 2012
Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2012
Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS - Related Lymphoma - Pipeline Review, H1 2012
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-Associated Lipodystrophy Syndrome - Pipeline Review, H1 2012
Topics: AIDS, HIV & STDs, Drug Discovery
| Global HIV/AIDS Testing Market 2010-2014
Topics: AIDS, HIV & STDs, Microbiology & Virology
Regions: Global
| AIDS-Related Opportunistic Infections - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs
| HIV / AIDS Global Clinical Trials Review, H2, 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| Global HIV Drugs Market 2010-2014
Topics: AIDS, HIV & STDs
Regions: Global
| Competitor Analysis: HIV Small Molecule Therapeutics
Topics: AIDS, HIV & STDs, Drug Discovery
| Global HIV Therapeutics Market Analysis
Topics: AIDS, HIV & STDs
Regions: Global
| Anal Fissure Global Clinical Trials Review, H2, 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Chlamydia Infections Global Clinical Trials Review, H2, 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Syphilis Global Clinical Trials Review, H2, 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Chlamydia Infections - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery, Women's Health, Men's Health
| HIV Pain - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery, Dentistry/Oral
| Global HIV/AIDS Diagnostics Market: Growth Opportunities and Business Expansion Strategies
Topics: AIDS, HIV & STDs, Microbiology & Virology
| HIV/AIDS Statistics in the Republic of South Africa (RSA): An Analysis of HIV/AIDS Mortality Comparing Death Counts, Surveillance Data, and Modeled Estimates
Topics: AIDS, HIV & STDs
Regions: South Africa
| HIV Drugs Market in India 2010-2014
Topics: AIDS, HIV & STDs
Regions: India
| HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain Market Growth Despite Major Patent Expiries
Topics: AIDS, HIV & STDs
| Special Report: Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets
Topics: AIDS, HIV & STDs, Tuberculosis, Prescription Drugs, Drug Discovery
| Competitor Analysis: HIV Vaccines
Topics: AIDS, HIV & STDs, Vaccines
| Herpes Simplex Infections - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs
| Herpes Zoster (Shingles) - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV / AIDS - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-1 Infection - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Genital Herpes - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs
| Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: AIDS, HIV & STDs, Drug Discovery, Reproductive Health
| AIDS - Related Cancers - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery, Oncology/Hematology
| Gilead's newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, Atripla
Topics: AIDS, HIV & STDs, Prescription Drugs
| The HIV Market Outlook to 2016
Topics: AIDS, HIV & STDs
| HIV-Associated Lipodystrophy Syndrome - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs
| AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs, Oncology/Hematology
| AIDS Associated Dementia - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Aids - Related Lymphoma - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Epidemiology: HIV - Antiretrovirals prevail as patient population grows
Topics: AIDS, HIV & STDs
| Molecular Diagnostics in Infectious Disease Testing
Topics: Genomics, Proteomics, AIDS, HIV & STDs, Hepatitis, Molecular Diagnostics, Infectious Diseases
| HIV-Associated Lipodystrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| AIDS-Related Opportunistic Infections - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-1 Infection Global Clinical Trials Review, Q2, 2011
Topics: AIDS, HIV & STDs
| Key Companies: HIV - Companies co-operate and co-formulate to stay competitive in a tight HIV market
Topics: AIDS, HIV & STDs
| AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs, Research & Development
| AIDS-Related Kaposi's Sarcoma (ARKS) Therapeutics -Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
Topics: AIDS, HIV & STDs, Hepatitis, Blood Banking & Tissue Typing, Histology & Cytology
Regions: Japan, United States, Europe
| Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Herpes Labialis (Oral Herpes) - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs
| HIV Pain - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Chlamydia Infections - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Specialty Pharmaceutical Industry - 2011 Yearbook
Topics: AIDS, HIV & STDs, Pharmaceuticals Company Reports, Manufacturing, Packaging & Detailing, Research & Development, Prescription Drugs, Rheumatology/Arthritis
| HIV-AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
|
Prev | 1 | 2 | 3 | 4 | Next
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2012
|
